Growth following solid-organ transplantation

Pediatric Transplantation

Volumn 6, Issue 1, 2002, Pages 47-52

  Fine, Richard N ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Growth; Solid organ transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DEFLAZACORT; PREDNISONE;

BODY HEIGHT; CATCH UP GROWTH; CHILD GROWTH; CONFERENCE PAPER; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION;

CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GROWTH; HUMANS; INFANT; INTESTINE, SMALL; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; RISK ASSESSMENT;

EID: 0036205503     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.1p067.x     Document Type: Conference Paper

References (38)

1. Growth in children with renal disease with particular reference to effects of caloric malnutrition: A review
2. Growth factors in children with endstage liver disease before and after liver transplantation: A review
3. Growth and pubertal development following pediatric heart transplantation: A 15 year experience at Ste-Justine Hospital
4. Pediatric lung transplantation at St. Louis Children's Hospital 1990-95
5. Assessment of function, growth and development, and long-term quality of life after small bowel transplantation
6. Long-term follow up of growth in children post-transplantation
7. Factors predictive of sustained growth in children after renal transplantation
8. A longitudinal study of the natural history of growth post- transplantation
9. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function
10. Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy
11. Pediatric renal transplantation under tacrolimus-based immunosuppression
12. Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation
13. Extended recombinant human growth hormone treatment after renal transplantation in children
14. Acute renal allograft rejection after treatment with human growth hormone
15. Cadaveric renal allograft rejection after treatment with recombinant human growth hormone
16. Accelerated growth rates in children treated with growth hormone after renal transplantation
17. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant
18. Randomized controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients
19. Effects of growth hormone in short children after renal transplantation
20. rhGH post-transplant: One year randomized control study of NAPRTCS
21. Development of renal cell carcinoma in living donor kidney grafts
22. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation
23. Factors affecting growth after pediatric liver transplantation
24. Linear growth after pediatric liver transplantation
25. Growth of long-term survivors of liver transplantation
26. Long-term follow-up of growth in height after successful liver transplantation
27. Steroid withdrawal in liver transplantation
28. A randomized prospective trial of steroid withdrawal after liver transplantation
29. Growth delay after liver transplantation in childhood: Studies of underlying mechanisms
30. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation
31. Pediatric heart transplantation at Stanford: Results of a 15 year experience
32. Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppression
33. Somatic growth in infant heart transplant recipients
34. Infant and donor organ growth after heart transplantation in neonates with hypoplastic left heart syndrome
35. Pediatric lung transplantation at St. Louis Children's Hospital, 1990-95
36. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation